Lifestyle « Weekly Gravy

Americans are losing sleep over worries about money, a new survey reveals. The American Academy of Sleep Medicine (AASM) polled about 2,000 U.S. adults, finding that 69% reported lost sleep due to concerns about job security and 75% were kept up with thoughts about whether the United States would enter a recession. “Persistent, anxious thoughts can make it difficult to fall asleep and impact sleep quality, so it’s understandable that a substantial number of Americans are losing sleep during this period of economic instability, inflation and job market insecurity,” said Dr. Susheel Patil, sleep medicine physician and spokesperson for the AASM. Still, suffering prolonged sleep disturbances can have some negative side effects in work and life, including decreased productivity, impaired decision-making and an increased risk of mental and physical health issues, according to the AASM. This anxiety can worsen at night, just when someone should be winding down. The AASM suggests measures to improve slumber, including keeping a regular sleep schedule by going to bed and waking at the same times each day, including weekends and holidays. Some other tips include: Try to get at least seven hours of sleep a night. Make your bedroom a peaceful sanctuary, with limited noise and distractions. It should be quiet, dark and cool. Only use your bed for sleeping, not watching TV or reading. Your nightly routine should… read on > read on >

The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug ketamine, often taken for psychiatric disorders. Compounded products are not evaluated by the FDA for safety and effectiveness. They’re also not regulated like approved drugs, so they present a greater risk. “Although compounded drugs can serve an important medical need for certain patients when an FDA-approved drug is not medically appropriate, they also present a risk to patients and should only be used under the care of a health care provider,” the FDA said in a news release. It offered an example of a concerning case reported about a patient in April. That person had taken compounded oral ketamine outside of a health care setting for the treatment of post-traumatic stress disorder (PTSD). The result was slowed breathing and a ketamine blood level that appeared to be twice what a person would typically receive as anesthesia, the FDA said. Patients are increasingly interested in taking compounded ketamine products, including oral formulations, for mental health disorders including depression, anxiety, PTSD and obsessive-compulsive disorder, according to the FDA. Known safety concerns associated with the drug are abuse and misuse, psychiatric events, increases in blood pressure, slowed breathing and lower urinary tract and bladder symptoms. In the FDA-approved version of ketamine, the expected benefit outweighs these risks when used at… read on > read on >

Cigarette makers are using synthetic menthol substitutes in what appears to be an effort to skirt a looming federal menthol ban, researchers say. The menthol flavor appeals to younger and newer smokers, according to investigators at Duke Health in Durham, N.C., and Yale University in New Haven, Conn. These new “non-menthol” cigarettes are being introduced in states that have already banned actual menthol in advance of a U.S. Food and Drug Administration ban later this year. In studying these “non-menthol” products, researchers identified new compounds that achieve cooling sensations similar to menthol. “We found that tobacco companies are adding a synthetic cooling agent called WS-3 to these new ‘non-menthol’ cigarettes,” said senior author Sven-Eric Jordt, an associate professor at Duke University School of Medicine. “The added amounts are sufficient to produce robust cooling sensations, with some brands having more cooling activity than their menthol equivalent cigarettes,” he said in a university news release California and Massachusetts have already banned menthol cigarettes. After California’s December 2022 ban, RJ Reynolds and ITG introduced non-menthol cigarettes with packaging and marketing strategies similar to those of menthol products. Lead author Sairam Jabba, a senior research scientist at Duke, measured whether cigarettes purchased in the two states with bans contained chemicals that activate the cold/menthol receptor. “We found that four of the non-menthol cigarette products, all manufactured by RJ Reynolds,… read on > read on >

Toilet bowls reveal much about the health of a community, alerting scientists to coming outbreaks of flu and other seasonal viruses, researchers say. “Just one flush can hold a lot of information,” said Kristine Du, co-author of a new Canadian study. “Wastewater surveillance equips public health experts, clinicians, policymakers and the public with community-based, objective data to inform health and safety decisions against the flu and RSV,” said Du, a lab technician at the University of Calgary School of Medicine. “Knowing what viruses are coming down the pike can help prepare individuals and communities appropriately,” she added in a university news release. Du and her colleagues found that the clinical cases of influenza A and B, as well as respiratory syncytial virus (RSV) correlated closely with virus positivity rates from wastewater surveillance in Calgary. Wastewater surveillance rose in prominence during the COVID-19 pandemic, and this new research builds on that. The study included data from weekly collections of 24-hour composite wastewater samples from three treatment plants in Calgary between March 2022 and April 2023. The samples were then compared to clinical data for total cases and test positivity rates across Calgary and Alberta. The researchers found that influenza A peaked in Calgary’s wastewater between November and December 2022. Influenza B peaked between February and April 2023. RSV’s peak was between November 2022 and February 2023.… read on > read on >

The signs of climate change are everywhere, from raging wildfires to flash flooding to soaring temperatures. Now, a new study warns that things could get worse, with scientists reporting that even small increases in global temperatures will make some parts of the Earth too hot for humans to endure. “As long as we continue to put greenhouse gases emissions into the atmosphere, we’re going to continue warming,” said study author Daniel Vecellio, a postdoctoral research scholar at the George Mason University’s Virginia Climate Center. “The take-home message is that we want to keep global warming to as much of a minimum as we can,” said Vecellio, who conducted the research while at Penn State University. “The easiest thing to say, but I guess as we see the hardest thing to do is to accelerate our reductions in greenhouse gas emissions as quickly as possible in order to stave off these worst effects.” In the study, scientists used lab-measured, physiologically-based temperature thresholds at a range of air temperatures and relative humidity. The team modeled global temperature increases ranging from 1.5 degrees Celsius (C) to 4 degrees C (2.7 degrees F to 7.2 degrees F) above what temperatures were when the industrial revolution began. The Paris Agreement, signed by 196 nations from around the world in 2015, aims to limit those increases to 1.5 C. The threshold… read on > read on >

As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution. The drugs are not well-tolerated by everyone struggling with obesity. For some folks, the weight piles back on as soon as the medication stops. There are also financial and ethical considerations, according to a commentary published online recently in the Journal of Clinical Investigation. More research is needed to better understand the medications, said endocrinologist Dr. Michael Schwartz from the University of Washington School of Medicine, in Seattle. Many experts seem to be saying “OK, we’ve fixed this problem. We’re done,” said Schwartz, co-director of the school’s Diabetes Institute and a co-author of the commentary. “We shouldn’t be complacent, and assume that these drugs are the answer to these chronic conditions,” Schwartz said in a university news release. “We are giving drugs where we don’t understand totally how they work.” Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration for treatment of obesity, a problem affecting about 42% of the U.S. population. Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes, but are also prescribed for weight loss. The medications mimic the action of naturally produced hormones, including glucagon-like peptide-1 (GLP-1). Patients feel full when eating less because of the increase in insulin, appetite suppression… read on > read on >

A California bill would have made free condoms available for high schoolers, but it was vetoed Sunday by Gov. Gavin Newsom because of cost. California has a budget deficit of $30 billion, Newsom noted in his veto of Senate Bill 541. This bill, plus several other measures lawmakers passed, would have increased state budget costs by $19 billion. “This bill would create an unfunded mandate to public schools that should be considered in the annual budget process,” the Democratic governor wrote. If the bill had been allowed to go through, it would have required public schools with grades 9 through 12 to make condoms available and free for all students. Those with grades 7 through 12 would have been required to allow condoms to be available as part of educational or public health programs. The state has 1.9 million high school students in more than 4,000 schools, the Associated Press reported. Under the bill, retailers would also have not been allowed to refuse to sell condoms to youth. The bill would have helped “youth who decide to become sexually active to protect themselves and their partners from [sexually transmitted infections], while also removing barriers that potentially shame them and lead to unsafe sex,” said the bill’s author, State Sen. Caroline Menjivar, a Democrat from Los Angeles, the AP reported. Newsom said programs that increase access… read on > read on >

Exercise has been dubbed “nature’s antidepressant” by doctors for years, and now a new study confirms the notion. The finding follows a four-month look at the impact that running had on anxiety and depression when compared to a common antidepressant. SSRIs (selective serotonin reuptake inhibitors) work by boosting levels of serotonin, a neurotransmitter that’s a key player when it comes to regulating mood, depression and anxiety. But among 140 depression patients, those who engaged in regular group running — meaning two or three 45-minute runs each week — actually saw their depression levels drop a bit more than those who took the popular SSRI medication escitalopram (Lexapro). And those who treated their depression with exercise reaped an added reward, with improvements seen in their physical health as well. That group, said study author Brenda Penninx, also “lost weight, improved fitness and reduced heart rate and blood pressure.” The medication group did not see those benefits. Penninx, a professor of psychiatric epidemiology and vice chair of the department of psychiatry at Amsterdam University Medical Center in the Netherlands, presented her findings this weekend at the ECNP meeting, which focuses on the science and treatment of brain disorders. The research was published earlier this year in the Journal of Affective Disorders. All told, she said, the findings suggest that “we should pay much more attention to lifestyle… read on > read on >

Former pro football players with symptoms of depression or anxiety are far more likely to receive an unverifiable diagnosis of chronic traumatic encephalopathy (CTE) than players without those mental health conditions, a new study reports. Players with depression are 9.5 times more likely to be diagnosed with CTE, while players with both depression and anxiety are 12 times more likely, the study results showed. The problem: At this point CTE can only be diagnosed as part of a brain autopsy. “CTE can only be diagnosed after death,” said lead author Shawn Eagle, a research assistant professor of neurological surgery at the University of Pittsburgh School of Medicine. “It shouldn’t be diagnosed in anyone while they’re living. Being told you have CTE when you’re alive is a problem because there’s no valid test to diagnose CTE in a living person.” Researchers argue that those players’ doctors are dropping the ball by handing out a CTE diagnosis, because there are effective treatments for the mood disorders that led to the diagnosis. “Depression, anxiety and sleep apnea produce cognitive symptoms, are treatable conditions, and should be distinguished from neurodegenerative disease,” Eagle said. “CTE is a neurodegenerative disease without available treatments or available diagnosis in a living person.” CTE is a degenerative brain disease that can be caused by repeated head impacts and concussions. It usually affects athletes who… read on > read on >

New research suggests that concert goers may synchronize their breathing and more as they listen to the intricacies of a classical symphony performance. Previous studies have shown that music may be able to induce synchronization in listeners, but the authors of this study said there has been little investigation into whether concert audiences actually become synchronized. This new study, involving 132 participants, suggests that heart rate, breathing rate and the electrical conductivity of skin (which suggests excitement) may synchronize between audience members at classical concerts. People who rated more highly for personality traits such as agreeableness or openness were more likely to synchronize with other audience members. Those with neurotic or extravert traits were less likely to become synchronized. The researchers, led by Wolfgang Tschacher, from the University Hospital of Psychiatry and Psychotherapy, in Bern, Switzerland, observed the 132 people while they listened to a concert in which three classical music pieces were played by a string quintet. They were Ludwig van Beethoven’s “Op. 104 in C minor,” Brett Dean’s “Epitaphs,” and Johannes Brahms’ “Op. 111 in G major.” The research team monitored participants’ movement using overhead cameras and measured their physical responses with wearable sensors. They also asked the participants to fill in questionnaires about their personality and mood both before and after the concert. While the investigators saw synchronization in a variety of… read on > read on >